🫁

Acute Respiratory Distress Syndrome (ARDS)

Jul 15, 2024

Acute Respiratory Distress Syndrome (ARDS) Lecture Notes

Introduction

  • Presenter: Ninja Nerds
  • Topic: Acute Respiratory Distress Syndrome (ARDS)
  • Section: Clinical Medicine
  • Call to Action:
    • Like, comment, and subscribe
    • Check out their website for notes, illustrations, question banks, exam prep courses, and merchandise

Definition & Criteria

  • Definition: ARDS is characterized by acute hypoxemia, bilateral pulmonary infiltrates, and non-cardiogenic pulmonary edema.
  • Key Criteria (Berlin Criteria):
    • Acute hypoxemia
      • SpO2 < 90% or PaO2 < 60 mmHg
      • Developed within less than a week
    • PF ratio < 300 (PaO2/FIO2)
    • Diffuse bilateral infiltrates on chest imaging
    • Non-cardiogenic pulmonary edema (PCWP < 18 mmHg via Swan-Ganz catheter or echocardiogram)

Pathophysiology

  • Initial Injury: Damage to alveolar cells (Type I and Type II cells)
    • Type I cell injury: Fluid, proteins, and immune cells fill alveoli, causing exudative phase and shunting (low V/Q mismatch)
    • Type II cell injury: Decreased surfactant leads to alveolar collapse and shunting
  • V/Q Mismatch: Both alveolar filling and collapse lead to significant hypoxemia
  • Primary Causes of Damage:
    • Direct Lung Injury
      • Pneumonia (e.g., SARS-CoV2)
      • Aspiration
      • Inhaled toxins (e.g., smoke inhalation)
    • Indirect Lung Injury (systemic causes)
      • Sepsis
      • Pancreatitis
      • Transfusion-Associated Lung Injury (TRALI)

Complications

  • Pulmonary Hypertension:
    • Hypoxic vasoconstriction → increased PVR → increased PAP → worsened V/Q mismatch and potential right heart failure
    • Signs of right heart failure: JVD, hepatomegaly, ascites, pedal edema
  • Intubation Complications:
    • Ventilator-associated pneumonia (VAP): Increased risk of infection from prolonged intubation
    • Ventilator-induced lung injury (VILI):
      • High PEEP or tidal volumes lead to alveolar rupture and pneumothorax
      • Decreased PEEP leads to alveolar de-recruitment and increased work of breathing
      • High FiO2 can cause free radical damage and V/Q mismatch

Diagnosis

  • Acute Onset: Symptoms develop within one week
  • PF Ratio: PaO2/FIO2 < 300
    • Severity:
      • Mild: 200-300
      • Moderate: 100-200
      • Severe: < 100
  • Chest Imaging: Diffuse bilateral opacities on chest x-ray or CT
  • Non-cardiogenic Origin: Confirmed through Echo or Swan-Ganz catheter showing PCWP < 18

Management

  • Initial Management:
    • Sedation to sync with ventilator (Propofol, Midazolam)
    • Maintain normal volume status to avoid fluid overload
    • Low tidal volume ventilation (6 cc/kg of ideal body weight)
    • High PEEP to prevent alveolar collapse
  • Advanced Management:
    • Neuromuscular blockade if PF ratio < 150 (helps to sync with ventilator and reduce respiratory effort)
    • Prone positioning if PF ratio < 150 (reduces dependent atelectasis and improves oxygenation)
    • Consider pulmonary vasodilators for refractory hypoxemia and RV dysfunction
    • VV ECMO (veno-venous extracorporeal membrane oxygenation) as a last resort if all other measures fail
  • Ventilator Settings: Key Points
    • Respiratory Rate (RR) & Tidal Volume (TV): Increase RR or TV to decrease PCO2; decrease RR or TV to increase PCO2
    • PEEP & FiO2: Increase PEEP or FiO2 to increase PO2; decrease PEEP or FiO2 to decrease PO2
    • Plateau Pressure: Keep < 30 cm H2O to avoid Barotrauma
  • Spontaneous Breathing Trials (SBTs):
    • Ensure underlying issue is resolved
    • Minimal FiO2 and PEEP requirements
    • Check Rapid Shallow Breathing Index (RSBI) to assess readiness for extubation

Conclusion

  • Review: Diagnosing ARDS involves evaluating for acute hypoxemia, specific PF ratio, imaging for infiltrates, and ruling out cardiogenic causes.
  • Management Focus: Prevent further lung injury through careful ventilator management, supportive care, and advanced therapies if necessary.
  • Call to Action: Apply these principles to clinical practice for better patient outcomes.